Solutions
Insulin
VanishPoint Insulin Syringe
Immunization
VanishPoint Syringe
EasyPoint Needle
Blood Collection
EasyPoint Blood Collection Tube with Needle
VanishPoint Blood Collection Set
Allergy
VanishPoint Syringe
General Purpose
VanishPoint Syringe
EasyPoint Needle
Infusion
VanishPoint IV Catheter
Products
VanishPoint Syringe
VanishPoint Insulin Syringes
EasyPoint Needle
EasyPoint Blood Collection Tube with Needle
VanishPoint Blood Collection Set
VanishPoint IV Catheter
About
Careers
Investor Relations
Media
Blog
Nurse Point Magazine
Press Releases
Resources
Contact
Sales Directory
Social Media
Social Media
Social Media
Questioning $1 Million Fee in a Needle Deal
rodneyhoganii
July 19, 2002
July 19, 2002
July 19, 2002
Press Releases
Questioning $1 Million Fee in a Needle Deal
Questioning $1 Million Fee in a Needle Deal
New York Times released an article today related to healthcare purchasing.
The article may be accessed by using the link below:
http://216.234.225.2/external.asp?b=577&id=69&from=pl
Previous Post
Next Post
Social Share
Social Share
Social Share
YOU MAY ALSO LIKE
Our Latest Posts
August 14, 2026
August 14, 2026
Retractable Technologies, Inc. Results for the Periods Ended June 30, 2026
June 30, 2026
June 30, 2026
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
May 15, 2026
May 15, 2026
Retractable Technologies, Inc. Results for the Period Ended March 31, 2026
April 9, 2026
April 9, 2026
Retractable Technologies, Inc. Announces Workforce Reduction